VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies
1 other identifier
observational
950
1 country
27
Brief Summary
The purpose of this study is to collect data from pacemakers and determine how this information is used by physicians to care for their patients with pacemakers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2002
Typical duration for all trials
27 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2002
CompletedFirst Submitted
Initial submission to the registry
February 16, 2006
CompletedFirst Posted
Study publicly available on registry
February 20, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2006
CompletedMarch 27, 2007
March 1, 2007
February 16, 2006
March 26, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Class I or Class II indication for dual chamber pacing
You may not qualify if:
- Has an ICD or is a known candidate for an ICD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtronic Cardiac Rhythm and Heart Failurelead
- Medtroniccollaborator
- Medtronic BRCcollaborator
Study Sites (27)
Unknown Facility
Hot Springs, Arkansas, United States
Unknown Facility
Little Rock, Arkansas, United States
Unknown Facility
North Little Rock, Arkansas, United States
Unknown Facility
Fort Lauderdale, Florida, United States
Unknown Facility
Largo, Florida, United States
Unknown Facility
Ormond Beach, Florida, United States
Unknown Facility
St. Petersburg, Florida, United States
Unknown Facility
Chicago, Illinois, United States
Unknown Facility
Edgewood, Kentucky, United States
Unknown Facility
Louisville, Kentucky, United States
Unknown Facility
Hyannis, Massachusetts, United States
Unknown Facility
Lansing, Michigan, United States
Unknown Facility
Bay Shore, New York, United States
Unknown Facility
Syracuse, New York, United States
Unknown Facility
Bismarck, North Dakota, United States
Unknown Facility
Barberton, Ohio, United States
Unknown Facility
Cincinnati, Ohio, United States
Unknown Facility
Marion, Ohio, United States
Unknown Facility
Massillon, Ohio, United States
Unknown Facility
Middletown, Ohio, United States
Unknown Facility
Pittsburgh, Pennsylvania, United States
Unknown Facility
Columbia, South Carolina, United States
Unknown Facility
Arlington, Texas, United States
Unknown Facility
Austin, Texas, United States
Unknown Facility
Beaumont, Texas, United States
Unknown Facility
McKinney, Texas, United States
Unknown Facility
Waukesha, Wisconsin, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Norman Jaffe, MD
Onondaga Hill Cardiovascular Group
- PRINCIPAL INVESTIGATOR
Luis Caceres, MD
Prairie Cardiovascular Consultants
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 16, 2006
First Posted
February 20, 2006
Study Start
October 1, 2002
Study Completion
May 1, 2006
Last Updated
March 27, 2007
Record last verified: 2007-03